Zhongfu Pharmaceutical Co., Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Zhongfu Pharmaceutical Co., Ltd.

58 YRS

Shandong, China

CNY 78.4 Million

66600 m²

100-500 people

Main Products: Captopril

Shandong, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

CRO

Total Employees

100-500 People

Plant Size

100 Acres

Production Experience

58+ Years

Registered Capital

CNY 78.4 Million

MAIN
PRODUCTS

1/3

Captopril

CAS: 62571-86-2

Packing: 25 KG/Fibre Drum

Lead Time: In Stock

Inquiry

ABOUT US

Zhongfu Pharmaceutical Co., Ltd.

Zhongfu Pharmaceutical Co., Ltd mainly manufactures small volume water injections, powder for injections, tablets & capsules and APIs. The capacity is: 100 million of small volume water injections, 180 million of powder injections, one billion of tablets and capsules and 140 tons of APIs. The QC department is equipped with modern analytical instruments which can fully satisfy the analysis requirements to APIs, raw materials, chemical intermediates and R&D use. We set up perfect quality assurance system and quality control in every procedure which assure the quality of products. All of the facilities are GMP approved, operating with cGMP. Especially, among them, the Captopril API workshop was approved by US FDA in 1998 and passed the re-inspection of US FDA in 2004 with ZERO 483, we got COS certificate in 2007. We have set up business relationships with foreign partners for APIs including Captopril, Lisinopril, Hydralazine Hydrochloride etc. as well as finished dosage forms. We hold the DMF with CTD format for Lisinopril, Gemfibrozil and Hydralazine HCl; several finished dosage form including water injectable, power injection and oral dosage have been registered in EU and Africa and entered into the commercial supplying from 2007 going on.